<DOC>
	<DOCNO>NCT02369159</DOCNO>
	<brief_summary>This study evaluate safety , pharmacokinetics effectiveness single dose IV peramivir compare standard 5 day course oral oseltamivir treatment pediatric subject acute uncomplicated influenza . Two third participant receive peramivir , one third receive oseltamivir .</brief_summary>
	<brief_title>Safety , PK Effectiveness IV Peramivir Versus Oseltamivir Pediatric Subjects With Uncomplicated Influenza</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<mesh_term>Peramivir</mesh_term>
	<criteria>Key 1 . Clinical sign symptom consistent acute influenza infection consist oral temperature ≥ 100°F ( 37.8°C ) rectal temperature ≥ 101.3ºF ( ≥ 38.5ºC ) least one respiratory symptom ( cough rhinitis ) OR Positive influenza determine PCR Rapid Antigen Test 2 . Influenza symptom onset &lt; 48 hour Key 1 . Pregnant breastfeeding female 2 . Development symptom hospitalize 3 . Presence chronic disease illness may indicate increase risk influenzarelated complication 4 . Presence immunocompromised status</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>